PLUS1
159.14
-2.50 (-1.55%)
-2.50 (-1.55%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | JNJ | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -2.50 | -1.55% | 159.14 | 14:43:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 156.92 | 156.53 | 159.23 | 161.64 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 174,504 | 13,850,061 | $ 157.96 | $ 2,187,792,477 | 7,814,641 | 133.65 - 173.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:43:04 | 31 | $ 159.1331 | USD |
Johnson and Johnson Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 418.94B | 2.63B | 2.63B | $ 82.06B | $ 17.72B | 5.63 | 25.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 3.75 | 2.36% | - | - |
Johnson and Johnson News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/13/2021 | 14:37 | Dow Jones News | J&J Vaccine Halt Weighs on Dow Industrials |
| 4/13/2021 | 14:33 | Dow Jones News | J&J's Covid-19 Vaccine: How Does the One-Dose Shot Compare.. |
| 4/13/2021 | 13:56 | Dow Jones News | U.S. Seeks to Pause J&J Covid-19 Vaccine Use After Rare.. |
| 4/13/2021 | 13:33 | Dow Jones News | Dow Slides on J&J Vaccine Halt, Inflation Uptick |
| 4/13/2021 | 12:54 | Dow Jones News | U.S. Seeks to Pause J&J Covid-19 Vaccine Use After Rare.. |
| 4/13/2021 | 12:53 | Dow Jones News | Do J&J and AstraZeneca Vaccines Cause Blood Clots? What You.. |
| 4/13/2021 | 12:49 | Dow Jones News | Do J&J and AstraZeneca Vaccines Cause Blood Clots? What You.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 164.16 | 164.52 | 156.53 | 162.41 | 5,672,547 | -5.02 | -3.06% |
| 1 Month | 160.11 | 167.03 | 156.53 | 162.41 | 7,037,322 | -0.97 | -0.61% |
| 3 Months | 161.90 | 173.65 | 151.47 | 162.37 | 7,988,012 | -2.76 | -1.7% |
| 6 Months | 149.30 | 173.65 | 133.65 | 155.77 | 7,665,315 | 9.84 | 6.59% |
| 1 Year | 140.30 | 173.65 | 133.65 | 151.77 | 7,287,598 | 18.84 | 13.43% |
| 3 Years | 131.09 | 173.65 | 109.16 | 140.15 | 7,380,107 | 28.05 | 21.4% |
| 5 Years | 110.00 | 173.65 | 109.16 | 135.22 | 6,712,322 | 49.14 | 44.67% |
Johnson and Johnson Description
| Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States. |
